Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002417:Cattle; D003094:Collagen / Q000494:pharmacology; D005279:Fenoprofen / Q000494:pharmacology; D006801:Humans; D009288:Naproxen / Q000494:pharmacology; D010105:Oxygenases / Q000037:antagonists & inhibitors / Q000097:blood*; D010653:Phenylbutazone / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists; D013442:Sulfinpyrazone / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D012702:Serotonin Antagonists; D012701:Serotonin; D009288:Naproxen; D003094:Collagen; D010105:Oxygenases; D010653:Phenylbutazone; D001241:Aspirin; D005279:Fenoprofen; D013442:Sulfinpyrazone